Available Technologies

Find technologies available for licensing from UC Irvine.

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Real-Time Virtual Histology Biopsy of Tissue

A revolutionary laser-based micro-biopsy tool designed for minimally invasive, precise tissue sampling and real-time histological analysis.

Injectable Hydrogel Used for Sustained Delivery of Vaccine

This technology introduces a novel vaccine delivery system using thermosensitive hydrogels for sustained antigen release, aiming to improve immune response durability and breadth.

Prioritizable IMU Array (Prio-IMU) for Enhanced Pedestrian Navigation

This technology introduces a novel, cost-effective solution for improving the accuracy of pedestrian navigation systems under extreme conditions.

Hydrogels for Vascular Regeneration and Tissue Repair

This invention introduces a novel approach to tissue engineering through the development of gelatin-based hydrogels that promote vascular regeneration and tissue repair without the need for growth factors.

Field-Adaptable, Functionalized Textile For Battery-Free Body Area Networks

This technology revolutionizes health monitoring by integrating smart textiles with body area networks for real-time biometric data collection.

Non-invasive monitoring of hemodynamic parameters

This technology represents a breakthrough in non-invasive hemodynamic monitoring by utilizing coherent light to assess physiological parameters with high accuracy

3D Printed Marching Cubes

Researchers have translated a medical computational procedure into creating interactive 3D printed construction units.

A System And Method To Measure Intraocular Pressure Using Laser Speckle Imaging

A novel non-invasive method to measure intraocular pressure (IOP), offering a significant advancement in glaucoma management.


5270 California Avenue / Irvine,CA
92697-7700 / Tel: 949.824.2683
  • Facebook
  • Twitter
  • Twitter
  • Twitter
  • Twitter